Insel TR, Fenton WS. Psychiatric epidemiology: it’s not just about counting anymore. Arch Gen Psychiatry. 2005;62:590–2.
Collaborators, GBDMD. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137–50.
Borsboom D, Cramer AOJ, Kalis A. Brain disorders? Not really: Why network structures block reductionism in psychopathology research. Behav Brain Sci. 2018;42:e2.
Carvalho AF, Solmi M, Sanches M, Machado MO, Stubbs B, Ajnakina O, et al. Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders. Transl Psychiatry. 2020;10:152.
Leichsenring F, Steinert C, Rabung S, Ioannidis J. The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses. World Psychiatry. 2022;21:133–45.
Howes OD, Thase ME, Pillinger T. Treatment resistance in psychiatry: state of the art and new directions. Mol Psychiatry. 2022;27:58–72.
Uhlhaas PJ, Wood, SJ, Youth Mental Health: A Paradigm for Prevention and Early Intervention. Strüngmann Forum Reports. Vol. 28. 2020: MIT Press.
Fusar-Poli P, Correll CU, Arango C, Berk M, Patel V, Ioannidis J. Preventive psychiatry: a blueprint for improving the mental health of young people. World Psychiatry. 2021;20:200–21.
Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27:281–95.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.
McGorry PD, Killackey E, Yung A. Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry. 2008;7:148–56.
Lin A, Wood SJ, Nelson B, Beavan A, McGorry P, Yung AR. Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. Am J Psychiatry. 2015;172:249–58.
Chanen AM, Betts JK, Jackson H, Cotton SM, Gleeson J, Davey CG, et al. A comparison of adolescent versus young adult outpatients with first-presentation borderline personality disorder: findings from the MOBY randomized controlled trial. Can J Psychiatry. 2022;67:26–38.
Kalindjian N, Hirot F, Stona AC, Huas C, Godart N. Early detection of eating disorders: a scoping review. Eat Weight Disord. 2022;27:21–68.
Vieta E, Salagre E, Grande I, Carvalho AF, Fernandes BS, Berk M, et al. Early Intervention in Bipolar Disorder. Am J Psychiatry. 2018;175:411–26.
Radez J, Reardon T, Creswell C, Lawrence PJ, Evdoka-Burton G, Waite P. Why do children and adolescents (not) seek and access professional help for their mental health problems? A systematic review of quantitative and qualitative studies. Eur Child Adolesc Psychiatry. 2021;30:183–211.
Thompson, EJ, et al. Changes in the adult consequences of adolescent mental ill-health: findings from the 1958 and 1970 British birth cohorts. Psychol Med, 2021: 1-10.
Hafstad GS, Augusti EM. A lost generation? COVID-19 and adolescent mental health. Lancet Psychiatry. 2021;8:640–1.
Caspi A, Houts RM, Ambler A, Danese A, Elliott ML, Hariri A, et al. Longitudinal assessment of mental health disorders and comorbidities across 4 decades among participants in the dunedin birth cohort study. JAMA Netw Open. 2020;3:e203221.
Knudsen EI. Sensitive periods in the development of the brain and behavior. J Cogn Neurosci. 2004;16:1412–25.
Reh RK, Dias BG, Nelson CA, Kaufer D, Werker JF, Kolb B, et al. Critical period regulation across multiple timescales. Proc Natl Acad Sci USA. 2020;117:23242–51.
Hooks BM, Chen C. Critical periods in the visual system: changing views for a model of experience-dependent plasticity. Neuron. 2007;56:312–26.
Fuhrmann D, Knoll LJ, Blakemore SJ. Adolescence as a sensitive period of brain development. Trends Cogn Sci. 2015;19:558–66.
Essau CA, Lewinsohn PM, Olaya B, Seeley JR. Anxiety disorders in adolescents and psychosocial outcomes at age 30. J Affect Disord. 2014;163:125–32.
Gerhard DM, Meyer HC, Lee FS. An adolescent sensitive period for threat responding: impacts of stress and sex. Biol Psychiatry. 2021;89:651–8.
Pattwell SS, Duhoux S, Hartley CA, Johnson DC, Jing D, Elliott MD, et al. Altered fear learning across development in both mouse and human. Proc Natl Acad Sci USA. 2012;109:16318–23.
Pattwell SS, Liston C, Jing D, Ninan I, Yang RR, Witztum J, et al. Dynamic changes in neural circuitry during adolescence are associated with persistent attenuation of fear memories. Nat Commun. 2016;7:11475.
Nederhof E, van Oort FV, Bouma EM, Laceulle OM, Oldehinkel AJ, Ormel J. Predicting mental disorders from hypothalamic-pituitary-adrenal axis functioning: a 3-year follow-up in the TRAILS study. Psychol Med. 2015;45:2403–12.
Romeo RD. The metamorphosis of adolescent hormonal stress reactivity: a focus on animal models. Front Neuroendocrinol. 2018;49:43–51.
Gomes FV, Zhu X, Grace AA. The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability. Mol Psychiatry. 2020;25:3278–91.
Gunnar MR, DePasquale CE, Reid BM, Donzella B, Miller BS. Pubertal stress recalibration reverses the effects of early life stress in postinstitutionalized children. Proc Natl Acad Sci USA. 2019;116:23984–8.
DePasquale CE, Herzberg MP, Gunnar MR. The pubertal stress recalibration hypothesis: potential neural and behavioral consequences. Child Dev Perspect. 2021;15:249–56.
Sisk LM, Gee DG. Stress and adolescence: vulnerability and opportunity during a sensitive window of development. Curr Opin Psychol. 2022;44:286–92.
Larsen B, Luna B. Adolescence as a neurobiological critical period for the development of higher-order cognition. Neurosci Biobehav Rev. 2018;94:179–95.
Chini M, Hanganu-Opatz IL. Prefrontal cortex development in health and disease: lessons from rodents and humans. Trends Neurosci. 2021;44:227–40.
Caballero A, Flores-Barrera E, Cass DK, Tseng KY. Differential regulation of parvalbumin and calretinin interneurons in the prefrontal cortex during adolescence. Brain Struct Funct. 2014;219:395–406.
Larsen B, Cui Z, Adebimpe A, Pines A, Alexander-Bloch A, Bertolero M, et al. A developmental reduction of the excitation:inhibition ratio in association cortex during adolescence. Sci Adv. 2022;8:eabj8750.
Park BY, Paquola C, Bethlehem R, Benkarim O, Neuroscience in Psychiatry Network (NSPN) C, Mišić B, et al. Adolescent development of multiscale structural wiring and functional interactions in the human connectome. Proc Natl Acad Sci USA. 2022;119:e2116673119.
Jalbrzikowski M, Larsen B, Hallquist MN, Foran W, Calabro F, Luna B. Development of white matter microstructure and intrinsic functional connectivity between the amygdala and ventromedial prefrontal cortex: associations with anxiety and depression. Biol Psychiatry. 2017;82:511–21.
Calabro FJ, Murty VP, Jalbrzikowski M, Tervo-Clemmens B, Luna B. Development of hippocampal-prefrontal cortex interactions through adolescence. Cereb Cortex. 2020;30:1548–58.
Nabel EM, Garkun Y, Koike H, Sadahiro M, Liang A, Norman KJ, et al. Adolescent frontal top-down neurons receive heightened local drive to establish adult attentional behavior in mice. Nat Commun. 2020;11:3983.
Benoit LJ, Holt ES, Posani L, Fusi S, Harris AZ, Canetta S, et al. Adolescent thalamic inhibition leads to long-lasting impairments in prefrontal cortex function. Nat Neurosci. 2022;25:714–25.
Casey BJ, Heller AS, Gee DG, Cohen AO. Development of the emotional brain. Neurosci Lett. 2019;693:29–34.
Silvers JA. Adolescence as a pivotal period for emotion regulation development. Curr Opin Psychol. 2022;44:258–63.
Sheppes G, Suri G, Gross JJ. Emotion regulation and psychopathology. Annu Rev Clin Psychol. 2015;11:379–405.
Chapman AL. Borderline personality disorder and emotion dysregulation. Dev Psychopathol. 2019;31:1143–56.
Duell N, Steinberg L, Icenogle G, Chein J, Chaudhary N, Di Giunta L, et al. Age patterns in risk taking across the world. J Youth Adolesc. 2018;47:1052–72.
Jordan CJ, Andersen SL. Sensitive periods of substance abuse: early risk for the transition to dependence. Dev Cogn Neurosci. 2017;25:29–44.
Luciana M, Collins PF. Is adolescence a sensitive period for the development of incentive-reward motivation? Curr Top Behav Neurosci. 2022;53:79–99.
Verrico CD, Gu H, Peterson ML, Sampson AR, Lewis DA. Repeated Delta9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. Am J Psychiatry. 2014;171:416–25.
Andrews JL, Ahmed SP, Blakemore SJ. Navigating the social environment in adolescence: the role of social brain development. Biol Psychiatry. 2021;89:109–18.
Crone EA, Fuligni AJ. Self and others in adolescence. Annu Rev Psychol. 2020;71:447–69.
Blakemore SJ, Mills KL. Is adolescence a sensitive period for sociocultural processing? Annu Rev Psychol. 2014;65:187–207.
Smith AR, Steinberg L, Strang N, Chein J. Age differences in the impact of peers on adolescents’ and adults’ neural response to reward. Dev Cogn Neurosci. 2015;11:75–82.
Gruenenfelder-Steiger AE, Harris MA, Fend HA. Subjective and objective peer approval evaluations and self-esteem development: a test of reciprocal, prospective, and long-term effects. Dev Psychol. 2016;52:1563–77.
Bicks LK, Yamamuro K, Flanigan ME, Kim JM, Kato D, Lucas EK, et al. Prefrontal parvalbumin interneurons require juvenile social experience to establish adult social behavior. Nat Commun. 2020;11:1003.
Foulkes L, Blakemore SJ. Individual differences in adolescent mental health during COVID-19: The importance of peer relationship quality. Neuron. 2021;109:3203–5.
Paus T. Population neuroscience. Handb Clin Neurol. 2016;138:17–37.
Paus T. Population neuroscience: why and how. Hum Brain Mapp. 2010;31:891–903.
Paus, T, Population Neuroscience. 2013, Berlin/Heidelberg: Springer.
Masten AS, Cicchetti D. Developmental cascades. Dev Psychopathol. 2010;22:491–5.
Shah JL, Jones N, van Os J, McGorry PD, Gülöksüz S. Early intervention service systems for youth mental health: integrating pluripotentiality, clinical staging, and transdiagnostic lessons from early psychosis. Lancet Psychiatry. 2022;9:413–22.
Lahey BB, Lee SS, Sibley MH, Applegate B, Molina B, Pelham WE. Predictors of adolescent outcomes among 4-6-year-old children with attention-deficit/hyperactivity disorder. J Abnorm Psychol. 2016;125:168–81.
Arslan IB, Lucassen N, van Lier P, de Haan AD, Prinzie P. Early childhood internalizing problems, externalizing problems and their co-occurrence and (mal)adaptive functioning in emerging adulthood: a 16-year follow-up study. Soc Psychiatry Psychiatr Epidemiol. 2021;56:193–206.
Orben A, Przybylski AK, Blakemore SJ, Kievit RA. Windows of developmental sensitivity to social media. Nat Commun. 2022;13:1649.
Gee DG. When do sensitive periods emerge later in development? Trends Cogn Sci. 2022;26:97–98.
Guloksuz S, van Os J, Rutten BPF. The exposome paradigm and the complexities of environmental research in psychiatry. JAMA Psychiatry. 2018;75:985–6.
Choi KW, Wilson M, Ge T, Kandola A, Patel CJ, Lee SH, et al. Integrative analysis of genomic and exposomic influences on youth mental health. J Child Psychol Psychiatry. 2022;63:1196–205.
Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748–51.
Kotov R, Krueger RF, Watson D, Achenbach TM, Althoff RR, Bagby RM, et al. The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies. J Abnorm Psychol. 2017;126:454–77.
Durbin CE, Wilson S, MacDonald AW. Integrating development into the Research Domain Criteria (RDoC) framework: Introduction to the special section. J Psychopathol Clin Sci. 2022;131:535–41.
Casey BJ, Oliveri ME, Insel T. A neurodevelopmental perspective on the research domain criteria (RDoC) framework. Biol Psychiatry. 2014;76:350–3.
Fusar-Poli P, Salazar de Pablo G, Correll CU, Meyer-Lindenberg A, Millan MJ, Borgwardt S, et al. Prevention of psychosis: advances in detection, prognosis, and intervention. JAMA Psychiatry. 2020;77:755–65.
Van Meter AR, Burke C, Youngstrom EA, Faedda GL, Correll CU. The bipolar prodrome: meta-analysis of symptom prevalence prior to initial or recurrent mood episodes. J Am Acad Child Adolesc Psychiatry. 2016;55:543–55.
Stice E, Desjardins CD, Rohde P, Shaw H. Sequencing of symptom emergence in anorexia nervosa, bulimia nervosa, binge eating disorder, and purging disorder and relations of prodromal symptoms to future onset of these disorders. J Abnorm Psychol. 2021;130:377–87.
Benasi G, Fava GA, Guidi J. Prodromal symptoms in depression: a systematic review. Psychother Psychosom. 2021;90:365–72.
Fineberg NA, Dell’Osso B, Albert U, Maina G, Geller D, Carmi L, et al. Early intervention for obsessive compulsive disorder: An expert consensus statement. Eur Neuropsychopharmacol. 2019;29:549–65.
Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust NZJ Psychiatry. 2005;39:964–71.
Fusar-Poli P, Cappucciati M, Rutigliano G, Schultze-Lutter F, Bonoldi I, Borgwardt S, et al. At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry. 2015;14:322–32.
Salazar de Pablo G, Radua J, Pereira J, Bonoldi I, Arienti V, Besana F, et al. Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis. JAMA Psychiatry. 2021;78:970–8.
Cannon TD, Yu C, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, et al. An Individualized Risk Calculator for Research in Prodromal Psychosis. Am J Psychiatry. 2016;173:980–8.
Catalan A, Salazar de Pablo G, Aymerich C, Damiani S, Sordi V, Radua J, et al. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021;78:859–67.
Group, E.C.H.R.F.P.W, Jalbrzikowski M, Hayes RA, Wood SJ, Nordholm D, Zhou JH, et al. Association of structural magnetic resonance imaging measures with psychosis onset in individuals at clinical high risk for developing psychosis: an ENIGMA working group mega-analysis. JAMA Psychiatry. 2021;78:753–66.
Correll CU, Olvet DM, Auther AM, Hauser M, Kishimoto T, Carrión RE, et al. The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls. Bipolar Disord. 2014;16:505–22.
Bechdolf A, Ratheesh A, Cotton SM, Nelson B, Chanen AM, Betts J, et al. The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study. Bipolar Disord. 2014;16:493–504.
Waszczuk MA, Zavos HM, Gregory AM, Eley TC. The phenotypic and genetic structure of depression and anxiety disorder symptoms in childhood, adolescence, and young adulthood. JAMA Psychiatry. 2014;71:905–16.
Hickie IB, Scott EM, Hermens DF, Naismith SL, Guastella AJ, Kaur M, et al. Applying clinical staging to young people who present for mental health care. Early Inter Psychiatry. 2013;7:31–43.
Shah JL, Scott J, McGorry PD, Cross S, Keshavan MS, Nelson B, et al. Transdiagnostic clinical staging in youth mental health: a first international consensus statement. World Psychiatry. 2020;19:233–42.
McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N. Z J Psychiatry. 2006;40:616–22.
Bethlehem RAI, Seidlitz J, White SR, Vogel JW, Anderson KM, Adamson C, et al. Brain charts for the human lifespan. Nature. 2022;604:525–33.
Rutherford S, Fraza C, Dinga R, Kia SM, Wolfers T, Zabihi M, et al. Charting brain growth and aging at high spatial precision. Elife. 2022;11:e72904.
Marquand AF, Kia SM, Zabihi M, Wolfers T, Buitelaar JK, Beckmann CF. Conceptualizing mental disorders as deviations from normative functioning. Mol Psychiatry. 2019;24:1415–24.
McGorry PD, Mei C, Chanen A, Hodges C, Alvarez-Jimenez M, Killackey E. Designing and scaling up integrated youth mental health care. World Psychiatry. 2022;21:61–76.
Howes OD, Whitehurst T, Shatalina E, Townsend L, Onwordi EC, Mak T, et al. The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis. World Psychiatry. 2021;20:75–95.
Austin A, Flynn M, Richards K, Hodsoll J, Duarte TA, Robinson P, et al. Duration of untreated eating disorder and relationship to outcomes: A systematic review of the literature. Eur Eat Disord Rev. 2021;29:329–45.
Drancourt N, Etain B, Lajnef M, Henry C, Raust A, Cochet B, et al. Duration of untreated bipolar disorder: missed opportunities on the long road to optimal treatment. Acta Psychiatr Scand. 2013;127:136–44.
Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry. 2018;75:555–65.
Mei C, van der Gaag M, Nelson B, Smit F, Yuen HP, Berger M, et al. Preventive interventions for individuals at ultra high risk for psychosis: An updated and extended meta-analysis. Clin Psychol Rev. 2021;86:102005.
Hansen HG, Starzer M, Nilsson SF, Hjorthøj C, Albert N, Nordentoft M. Clinical recovery and long-term association of specialized early intervention services vs treatment as usual among individuals with first-episode schizophrenia spectrum disorder: 20-year follow-up of the OPUS trial. JAMA Psychiatry. 2023;80:371–9. p.
Chanen AM, Thompson KN. Early intervention for personality disorder. Curr Opin Psychol. 2018;21:132–5.
Stockings E, Hall WD, Lynskey M, Morley KI, Reavley N, Strang J, et al. Prevention, early intervention, harm reduction, and treatment of substance use in young people. Lancet Psychiatry. 2016;3:280–96.
Austin A, Flynn M, Shearer J, Long M, Allen K, Mountford VA, et al. The first episode rapid early intervention for eating disorders – upscaled study: clinical outcomes. Early Interv Psychiatry. 2022;16:97–105.
Casey BJ, Glatt CE, Lee FS. Treating the developing versus developed brain: translating preclinical mouse and human studies. Neuron. 2015;86:1358–68.
Lee H, Dvorak D, Kao HY, Duffy ÁM, Scharfman HE, Fenton AA. Early cognitive experience prevents adult deficits in a neurodevelopmental schizophrenia model. Neuron. 2012;75:714–24.
Cabungcal JH, Counotte DS, Lewis E, Tejeda HA, Piantadosi P, Pollock C, et al. Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia. Neuron. 2014;83:1073–84.
Mukherjee A, Carvalho F, Eliez S, Caroni P. Long-lasting rescue of network and cognitive dysfunction in a genetic schizophrenia model. Cell. 2019;178:1387–1402.e14.
Ginsburg GS, Becker-Haimes EM, Keeton C, Kendall PC, Iyengar S, Sakolsky D, et al. Results from the child/adolescent anxiety multimodal extended long-term study (CAMELS): primary anxiety outcomes. J Am Acad Child Adolesc Psychiatry. 2018;57:471–80.
Odriozola P, Gee DG. Learning about safety: conditioned inhibition as a novel approach to fear reduction targeting the developing brain. Am J Psychiatry. 2021;178:136–55.
Susai SR, Sabherwal S, Mongan D, Föcking M, Cotter DR. Omega-3 fatty acid in ultra-high-risk psychosis: a systematic review based on functional outcome. Early Inter Psychiatry. 2022;16:3–16.
Bradlow RCJ, Berk M, Kalivas PW, Back SE, Kanaan RA. The potential of N-Acetyl-L-cysteine (NAC) in the treatment of psychiatric disorders. CNS Drugs. 2022;36:451–82.
Chesney E, Oliver D, McGuire P. Cannabidiol (CBD) as a novel treatment in the early phases of psychosis. Psychopharmacol (Berl). 2022;239:1179–90.
McGorry PD, Tanti C, Stokes R, Hickie IB, Carnell K, Littlefield LK, et al. Headspace: Australia’s National Youth Mental Health Foundation–where young minds come first. Med J Aust. 2007;187:S68–70.
McGorry PD, Goldstone SD, Parker AG, Rickwood DJ, Hickie IB. Cultures for mental health care of young people: an Australian blueprint for reform. Lancet Psychiatry. 2014;1:559–68.
Rickwood, D, McEachran, J, Saw, A, Telford, N, Trethowan, J, McGorry, P, Sixteen years of innovation in youth mental healthcare in Australia: Outcomes for young people attending headspace centre services. medRxiv 2022. 2022.08.24.22279102.
Iorfino F, Scott EM, Hickie IB. Social and occupational outcomes for young people who attend early intervention mental health services: a longitudinal study. Med J Aust. 2022;217:218.
Iyer SN, Shah J, Boksa P, Lal S, Joober R, Andersson N, et al. A minimum evaluation protocol and stepped-wedge cluster randomized trial of ACCESS Open Minds, a large Canadian youth mental health services transformation project. BMC Psychiatry. 2019;19:273.
Abba-Aji A, Hay K, Kelland J, Mummery C, Urichuk L, Gerdes C, et al. Transforming youth mental health services in a large urban centre: ACCESS Open Minds Edmonton. Early Inter Psychiatry. 2019;13:14–19.
Boonstra, A, et al., @ease peer-to-peer youth walk-in centres in The Netherlands: A protocol for evaluating longitudinal outcomes, follow-up results and cost-of-illness. Early Interv Psychiatry, 2023.
Shah JL, Moinfar Z, Anderson KK, Gould H, Hutt-Macleod D, Jacobs P, et al. Return on investment from service transformation for young people experiencing mental health problems: Approach to economic evaluations in ACCESS Open Minds (Esprits ouverts), a multi-site pan-Canadian youth mental health project. Front Psychiatry. 2023;14:1030407.
Uhlhaas P, Torous J. Digital tools for youth mental health. NPJ Digit Med. 2019;2:104.
Lattie EG, Stiles-Shields C, Graham AK. An overview of and recommendations for more accessible digital mental health services. Nat Rev Psychol. 2022;1:87–100.
Domhardt M, Engler S, Nowak H, Lutsch A, Baumel A, Baumeister H. Mechanisms of Change in Digital Health Interventions for Mental Disorders in Youth: Systematic Review. J Med Internet Res. 2021;23:e29742.
Domhardt M, Messner EM, Eder AS, Engler S, Sander LB, Baumeister H, et al. Mobile-based interventions for common mental disorders in youth: a systematic evaluation of pediatric health apps. Child Adolesc Psychiatry Ment Health. 2021;15:49.
Gleeson J, Lederman R, Koval P, Wadley G, Bendall S, Cotton S, et al. Moderated Online Social Therapy: A Model for Reducing Stress in Carers of Young People Diagnosed with Mental Health Disorders. Front Psychol. 2017;8:485. p.
Alvarez-Jimenez M, Koval P, Schmaal L, Bendall S, O’Sullivan S, Cagliarini D, et al. The Horyzons project: a randomized controlled trial of a novel online social therapy to maintain treatment effects from specialist first-episode psychosis services. World Psychiatry. 2021;20:233–43.
Engel, L, Alvarez-Jimenez M, Cagliarini D, D’Alfonso S, Faller J, Valentine L, et al., The Cost-Effectiveness of a Novel Online Social Therapy to Maintain Treatment Effects From First-Episode Psychosis Services: Results From the Horyzons Randomized Controlled Trial. Schizophr Bull, 2023.
Chang S, Gray L, Torous J. Smartphone app engagement and clinical outcomes in a hybrid clinic. Psychiatry Res. 2023;319:115015.
Reininghaus U, Paetzold I, Rauschenberg C, Hirjak D, Banaschewski T, Meyer-Lindenberg A, et al. Effects of a novel, transdiagnostic ecological momentary intervention for prevention, and early intervention of severe mental disorder in youth (EMIcompass): findings from an exploratory randomized controlled trial. Schizophr Bull. 2023;49:592–604.
Fusar-Poli P, Sullivan SA, Shah JL, Uhlhaas PJ. Improving the detection of individuals at clinical risk for psychosis in the community, primary and secondary care: an integrated evidence-based approach. Front Psychiatry. 2019;10:774.
Cohen A, Naslund JA, Chang S, Nagendra S, Bhan A, Rozatkar A, et al. Relapse prediction in schizophrenia with smartphone digital phenotyping during COVID-19: a prospective, three-site, two-country, longitudinal study. Schizophrenia (Heidelb). 2023;9:6.
Torous J, Bucci S, Bell IH, Kessing LV, Faurholt-Jepsen M, Whelan P, et al. The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality. World Psychiatry. 2021;20:318–35.
Lloyd K, White J. Democratizing clinical research. Nature. 2011;474:277–8.
Baumann PS, Crespi S, Marion-Veyron R, Solida A, Thonney J, Favrod J, et al. Treatment and early intervention in psychosis program (TIPP-Lausanne): Implementation of an early intervention programme for psychosis in Switzerland. Early Inter Psychiatry. 2013;7:322–8.
Anderson KK, Norman R, MacDougall A, Edwards J, Palaniyappan L, Lau C, et al. Effectiveness of early psychosis intervention: comparison of service users and nonusers in population-based health administrative data. Am J Psychiatry. 2018;175:443–52.
Stockings EA, Degenhardt L, Dobbins T, Lee YY, Erskine HE, Whiteford HA, et al. Preventing depression and anxiety in young people: a review of the joint efficacy of universal, selective and indicated prevention. Psychol Med. 2016;46:11–26.
Breedvelt JJF, Kandola A, Kousoulis AA, Brouwer ME, Karyotaki E, Bockting C, et al. What are the effects of preventative interventions on major depressive disorder (MDD) in young adults? A systematic review and meta-analysis of randomized controlled trials. J Affect Disord. 2018;239:18–29.
Lawrence PJ, Rooke SM, Creswell C. Review: Prevention of anxiety among at-risk children and adolescents – a systematic review and meta-analysis. Child Adolesc Ment Health. 2017;22:118–30.
Carney T, Myers B. Effectiveness of early interventions for substance-using adolescents: findings from a systematic review and meta-analysis. Subst Abus Treat Prev Policy. 2012;7:25.
Addington J, Stowkowy J, Weiser M. Screening tools for clinical high risk for psychosis. Early Inter Psychiatry. 2015;9:345–56.
Powers AR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, et al. Duration of the psychosis prodrome. Schizophr Res. 2020;216:443–9.
Merritt K, McGuire PK, Egerton A, -MRS in Schizophrenia I, Aleman A, Block W, et al. Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: a mega-analysis of individual participant-level data. JAMA Psychiatry. 2021;78:667–81.
Van Meter A, Guinart D, Bashir A, Sareen A, Cornblatt BA, Auther A, et al. Bipolar prodrome symptom scale – abbreviated screen for patients: description and validation. J Affect Disord. 2019;249:357–65.
Sekhar DL, Schaefer EW, Waxmonsky JG, Walker-Harding LR, Pattison KL, Molinari A, et al. Screening in high schools to identify, evaluate, and lower depression among adolescents: a randomized clinical trial. JAMA Netw Open. 2021;4:e2131836.
Scott J, Graham A, Yung A, Morgan C, Bellivier F, Etain B. A systematic review and meta-analysis of delayed help-seeking, delayed diagnosis and duration of untreated illness in bipolar disorders. Acta Psychiatr Scand. 2022;146:389–405.
Ghio L, Gotelli S, Marcenaro M, Amore M, Natta W. Duration of untreated illness and outcomes in unipolar depression: a systematic review and meta-analysis. J Affect Disord. 2014;152-154:45–51.
Chanen AM, Jovev M, Djaja D, McDougall E, Yuen HP, Rawlings D, et al. Screening for borderline personality disorder in outpatient youth. J Pers Disord. 2008;22:353–64.
Dierker LC, Albano AM, Clarke GN, Heimberg RG, Kendall PC, Merikangas KR, et al. Screening for anxiety and depression in early adolescence. J Am Acad Child Adolesc Psychiatry. 2001;40:929–36.
Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, Kessler RC. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:603–13.
Pilowsky DJ, Wu LT. Screening instruments for substance use and brief interventions targeting adolescents in primary care: a literature review. Addict Behav. 2013;38:2146–53.
Piqueras JA, Rodríguez-Jiménez T, Ortiz AG, Moreno E, Lázaro L, Godoy A. Validation of the Short Obsessive-Compulsive Disorder Screener (SOCS) in children and adolescents. BJPsych Open. 2015;1:21–26.
Morgan JF, Reid F, Lacey JH. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ. 1999;319:1467–8.
Bryant E, Miskovic-Wheatley J, Touyz SW, Crosby RD, Koreshe E, Maguire S. Identification of high risk and early stage eating disorders: first validation of a digital screening tool. J Eat Disord. 2021;9:109.
Andrés-Pepiñá S, Plana MT, Flamarique I, Romero S, Borràs R, Julià L, et al. Long-term outcome and psychiatric comorbidity of adolescent-onset anorexia nervosa. Clin Child Psychol Psychiatry. 2020;25:33–44. p.
Oliver, D, et al. Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis. Mol Psychiatry, 2022.
Erickson MA, Ruffle A, Gold JM. A meta-analysis of mismatch negativity in schizophrenia: from clinical risk to disease specificity and progression. Biol Psychiatry. 2016;79:980–7.
Koutsouleris N, Dwyer DB, Degenhardt F, Maj C, Urquijo-Castro MF, Sanfelici R, et al. Multimodal machine learning workflows for prediction of psychosis in patients with clinical high-risk syndromes and recent-onset depression. JAMA Psychiatry. 2021;78:195–209.
Fusar-Poli P, De Micheli A, Rocchetti M, Cappucciati M, Ramella-Cravaro V, Rutigliano G, et al. Semistructured Interview for Bipolar At Risk States (SIBARS). Psychiatry Res. 2018;264:302–9.
Birmaher B, Merranko JA, Goldstein TR, Gill MK, Goldstein BI, Hower H, et al. A risk calculator to predict the individual risk of conversion from subthreshold bipolar symptoms to bipolar disorder I or II in youth. J Am Acad Child Adolesc Psychiatry. 2018;57:755–763.e4.
Saraf G, Moazen-Zadeh E, Pinto JV, Ziafat K, Torres IJ, Kesavan M, et al. Early intervention for people at high risk of developing bipolar disorder: a systematic review of clinical trials. Lancet Psychiatry. 2021;8:64–75.
Werner-Seidler A, Perry Y, Calear AL, Newby JM, Christensen H. School-based depression and anxiety prevention programs for young people: A systematic review and meta-analysis. Clin Psychol Rev. 2017;51:30–47.
Hugh-Jones S, Beckett S, Tumelty E, Mallikarjun P. Indicated prevention interventions for anxiety in children and adolescents: a review and meta-analysis of school-based programs. Eur Child Adolesc Psychiatry. 2021;30:849–60.
Moreno-Peral P, Conejo-Cerón S, Rubio-Valera M, Fernández A, Navas-Campaña D, Rodríguez-Morejón A, et al. Effectiveness of psychological and/or educational interventions in the prevention of anxiety: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry. 2017;74:1021–9.
Norberg MM, Kezelman S, Lim-Howe N. Primary prevention of cannabis use: a systematic review of randomized controlled trials. PLoS One. 2013;8:e53187.
Jensen CD, Cushing CC, Aylward BS, Craig JT, Sorell DM, Steele RG. Effectiveness of motivational interviewing interventions for adolescent substance use behavior change: a meta-analytic review. J Consult Clin Psychol. 2011;79:433–40.
Shah JL. Bringing clinical staging to youth mental health: from concept to operationalization (and back again). JAMA Psychiatry. 2019;76:1121–3.